Paper894041
Cytotoxic reactivity of human lymphocytes cultured in vitro.
Ortaldo JR and 2 others. J Immunol, 1977. Cited by 187 papers, by iCite.
Cite this record
ConductScience Library. Cytotoxic reactivity of human lymphocytes cultured in vitro. Papers, record 894041. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/894041
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lymphocytes | Major topic |
| Binding Sites, Antibody | |
| Breast Neoplasms | |
| Cell Line | |
| Cells, Cultured | |
| Cytotoxicity Tests, Immunologic | |
| Humans | |
| Immunoglobulin Fc Fragments | |
| Leukocytes | |
| Liver | |
| Mitogens | |
| Tuberculin |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 187 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 11687452 | Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants. | Clin Diagn Lab Immunol | 2001 | https://conductscience.org/library/papers/11687452 | PubMed |
| 9415022 | Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids. | Immunology | 1997 | https://conductscience.org/library/papers/9415022 | PubMed |
| 8403515 | Peri-operative modulation of cellular immunity in patients with colorectal cancer. | Clin Exp Immunol | 1993 | https://conductscience.org/library/papers/8403515 | PubMed |
| 7947102 | The effect of 5-fluorouracil and alpha interferon and 5-fluorouracil and leucovorin on cellular anti-tumour immune responses in patients with advanced colorectal cancer. | Br J Cancer | 1994 | https://conductscience.org/library/papers/7947102 | PubMed |
| 7429543 | The in vitro discrimination of rat immune and natural cytotoxicity by serum choice. | Immunology | 1980 | https://conductscience.org/library/papers/7429543 | PubMed |
| 7353081 | Adenine and hypoxanthine metabolism in phythohemagglutinin-stimulated and unstimulated human lymphocytes. | Blut | 1980 | https://conductscience.org/library/papers/7353081 | PubMed |
| 7307338 | In vitro augmentation of human natural cytotoxic activity. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/7307338 | PubMed |
| 7251046 | Studies on the mechanism of rat natural cellular cytotoxicity and its inhibition by normal rat serum. | Immunology | 1981 | https://conductscience.org/library/papers/7251046 | PubMed |
| 7039896 | Spontaneous cytotoxicity of human peripheral blood mononuclear cells for the lymphoblastoid cell line CCRF-CEM: augmentation by bacterial lipopolysaccharide. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/7039896 | PubMed |
| 6983408 | Immune functions in methyl and ethyl carbamate treated mice. | Clin Exp Immunol | 1982 | https://conductscience.org/library/papers/6983408 | PubMed |
| 6947964 | Proliferative response of lymphocyte subpopulations differing in avidity for sheep red blood cells after stimulation with normal allogeneic and tumour cells. | Immunology | 1981 | https://conductscience.org/library/papers/6947964 | PubMed |
| 6690072 | Phase-I trial of UltrapureTM human leukocyte interferon in human malignancy. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6690072 | PubMed |
| 6604064 | Sézary cells with an unusual phenotype, their modulation with 12-O-tetradecanoyl phorbol-13-acetate (TPA) in vitro, and their relationship to T-cell development. | J Clin Immunol | 1983 | https://conductscience.org/library/papers/6604064 | PubMed |
| 6601174 | Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells. | J Exp Med | 1983 | https://conductscience.org/library/papers/6601174 | PubMed |
| 6466539 | Therapy with high dose recombinant alpha 2 interferon (IFN-alpha 2) produces a depression in natural killer cell cytotoxicity. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6466539 | PubMed |
| 6309674 | Natural killer cell activity in renal transplant recipients receiving cyclosporine. | Infect Immun | 1983 | https://conductscience.org/library/papers/6309674 | PubMed |
| 6177626 | Stimulation natural cytotoxic activity in mixed cell cultures and by culture supernatants containing interferon. | Immunology | 1982 | https://conductscience.org/library/papers/6177626 | PubMed |
| 6176669 | Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. | J Exp Med | 1982 | https://conductscience.org/library/papers/6176669 | PubMed |
| 6174540 | Augmentation of natural and antibody-dependent cell-mediated cytotoxicity by pure human leukocyte interferon. | J Clin Immunol | 1981 | https://conductscience.org/library/papers/6174540 | PubMed |
| 6092269 | Factors affecting the spontaneous cell-mediated cytotoxicity of intestinal mononuclear cells. | Immunology | 1984 | https://conductscience.org/library/papers/6092269 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/894041
GET https://conductscience.org/api/papers/v1/894041/cited_by?page=2